Cardiac hypertrophy involves the reexpression of foetal genes, including β-myosin heavy chain (β-MHC), ANP, and BNP, and these foetal genes were commonly used as cell markers to diagnose cardiac hypertrophy [21]. Here, NPPA is linked to cardiac hypertrophy.